US20210368442A1 - Methods of wireless communication in an infusion pump system - Google Patents
Methods of wireless communication in an infusion pump system Download PDFInfo
- Publication number
- US20210368442A1 US20210368442A1 US17/395,289 US202117395289A US2021368442A1 US 20210368442 A1 US20210368442 A1 US 20210368442A1 US 202117395289 A US202117395289 A US 202117395289A US 2021368442 A1 US2021368442 A1 US 2021368442A1
- Authority
- US
- United States
- Prior art keywords
- infusion pump
- pump
- electronic device
- consumer electronic
- communications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 90
- 238000004891 communication Methods 0.000 title claims abstract description 67
- 230000006854 communication Effects 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 30
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 35
- 239000008103 glucose Substances 0.000 claims abstract description 34
- 238000012544 monitoring process Methods 0.000 claims abstract description 16
- 238000002560 therapeutic procedure Methods 0.000 claims description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 20
- 102000004877 Insulin Human genes 0.000 description 10
- 108090001061 Insulin Proteins 0.000 description 10
- 229940125396 insulin Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000036541 health Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 102000051325 Glucagon Human genes 0.000 description 2
- 108060003199 Glucagon Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 2
- 229960004666 glucagon Drugs 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000010295 mobile communication Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229960003611 pramlintide Drugs 0.000 description 2
- 108010029667 pramlintide Proteins 0.000 description 2
- NRKVKVQDUCJPIZ-MKAGXXMWSA-N pramlintide acetate Chemical compound C([C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 NRKVKVQDUCJPIZ-MKAGXXMWSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- -1 for example Chemical compound 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940127560 insulin pen Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W52/00—Power management, e.g. TPC [Transmission Power Control], power saving or power classes
- H04W52/02—Power saving arrangements
- H04W52/0209—Power saving arrangements in terminal devices
- H04W52/0225—Power saving arrangements in terminal devices using monitoring of external events, e.g. the presence of a signal
- H04W52/0229—Power saving arrangements in terminal devices using monitoring of external events, e.g. the presence of a signal where the received signal is a wanted signal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04M—TELEPHONIC COMMUNICATION
- H04M1/00—Substation equipment, e.g. for use by subscribers
- H04M1/72—Mobile telephones; Cordless telephones, i.e. devices for establishing wireless links to base stations without route selection
- H04M1/724—User interfaces specially adapted for cordless or mobile telephones
- H04M1/72403—User interfaces specially adapted for cordless or mobile telephones with means for local support of applications that increase the functionality
- H04M1/72409—User interfaces specially adapted for cordless or mobile telephones with means for local support of applications that increase the functionality by interfacing with external accessories
- H04M1/72412—User interfaces specially adapted for cordless or mobile telephones with means for local support of applications that increase the functionality by interfacing with external accessories using two-way short-range wireless interfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/70—General characteristics of the apparatus with testing or calibration facilities
- A61M2205/702—General characteristics of the apparatus with testing or calibration facilities automatically during use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
- A61M2205/8212—Internal energy supply devices battery-operated with means or measures taken for minimising energy consumption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02D—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
- Y02D30/00—Reducing energy consumption in communication networks
- Y02D30/70—Reducing energy consumption in communication networks in wireless communication networks
Definitions
- the present invention is directed to portable infusion pumps and more particularly to systems enabling wireless control of infusion pumps.
- insulin injecting pumps developed for administering insulin to patients afflicted with type I, or in some cases, type II diabetes.
- Some insulin injecting pumps are configured as portable or ambulatory infusion devices can provide continuous subcutaneous insulin injection and/or infusion therapy as an alternative to multiple daily injections of insulin via a syringe or an insulin pen.
- Such pumps are worn by the user and may use replaceable cartridges.
- these pumps may also deliver medicaments other than, or in addition to, insulin, such as glucagon, pramlintide, and the like. Examples of such pumps and various features associated therewith include those disclosed in U.S. Patent Publication Nos. 2013/0324928 and 2013/0053816 and U.S. Pat. Nos. 8,287,495; 8,573,027; 8,986,253; and 9,381,297, each of which is incorporated herein by reference in its entirety.
- Ambulatory infusion pumps have generally been controlled by a user interface provided on the pump.
- handheld electronic devices such as mobile phones (e.g., smartphones)
- dedicated wireless controllers designed to work with one or more infusion pumps and/or types of infusion pumps, to optimize usage of infusion pumps.
- These remote controllers would enable a pump to be monitored, programmed and/or operated more privately, more conveniently and more comfortably.
- one potential use of dedicated remote devices and handheld consumer electronic devices is to utilize such devices as controllers for remotely programming and/or operating infusion pumps.
- portable infusion pumps are generally powered by portable batteries and frequent wireless communications with external devices can have a significant effect on infusion pump battery life.
- mobile control devices such as smartphones and dedicated remote controllers it may be beneficial to enable infusion pumps to communicate with other devices, such as continuous glucose monitors, glucose meters, and other health monitoring devices, for example. This places further burden on infusion pump battery life. It would therefore be desirable to configure such communications in a manner that reduces the strain on the infusion pump battery and otherwise increase the efficiency of such systems.
- Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other multi-purpose consumer electronic device and/or a dedicated remote controller for the infusion pump. Communications among these devices can be coordinated to increase efficiency and conserve battery power.
- CGM continuous glucose monitoring
- methods of communication in an infusion pump system in which an infusion pump can communicate with both a smartphone or other multi-purpose consumer electronic device and a dedicated remote controller are coordinated to preserve the pump battery. If only the smartphone or only the remote controller is present in the system at a given time, the device that is present communicates directly with and controls the pump. If the pump, smartphone and remote controller are all present, rather than the smartphone communicating directly with the pump, smartphone communications are instead routed through the remote controller. Similarly, if the smartphone is controlling the pump alone, but then detects that the remote controller has become available for communications, the smartphone will disconnect from the pump and connect to the remote controller to route smartphone communications through the remote controller.
- the dedicated remote controller may have full access to program and control the pump while the smartphone has more limited control of pump functionality. In such configurations, routing communications through the remote controller ensures full pump functionality.
- a method of coordinating wireless communications in an infusion pump system including an infusion pump, a multi-purpose consumer electronic device and a dedicated remote controller designed for use with the infusion pump.
- the infusion pump can be enabled to receive communications from both the multi-purpose consumer electronic device and the dedicated remote controller and carry out operating commands based on the communications. If it is determined that both the multi-purpose consumer electronic device and the dedicated remote controller are available for communication with the infusion pump, communications can be suspended between the infusion pump and the multi-purpose consumer electronic device. Communications generated by the multi-purpose consumer electronic device can then be routed to the dedicated remote controller and transmitted to the infusion pump with the dedicated remote controller.
- the infusion pump can execute operating commands based on the communications generated by the multi-purpose consumer electronic device after receiving the communications from the dedicated remote controller.
- communications between an infusion pump and a continuous glucose monitoring (CGM) system in a system that includes a smartphone or other remote control device can be coordinated to preserve pump battery.
- CGM continuous glucose monitoring
- the CGM system generally sends data to the pump on a periodic, continual basis, such as, for example, every five minutes.
- This data includes data sent by the pump in making therapy determinations such as data relating to glucose levels and trends of the patient as well as additional data not used by the pump such as diagnostic data relating to the performance of the CGM components.
- Communications in the system can be configured to separate the CGM data such that the data needed for therapy determinations is sent to the pump, but the diagnostic data that is not used by the pump is instead transmitted directly from the CGM system to the remote control device. Having this data go directly from the CGM to the remote control device lessens the effect of receiving, storing and transmitting the CGM data on the pump battery.
- a method of coordinating wireless communications in an infusion pump system including an infusion pump, a remote control device for remotely controlling the infusion pump, and a continuous glucose monitoring system.
- Data can be collected with the continuous glucose monitoring system and wireless communication established between the continuous glucose monitoring system and both the infusion pump and the remote control device.
- the data collected with the continuous glucose monitoring system can be separated into pump data that will be utilized to determine therapy parameters for the infusion pump and non-pump data relating to the continuous glucose monitoring system that are not used to determine therapy parameters for the infusion pump.
- the pump data can be transmitted to the infusion pump and the non-pump data to the remote control device to conserve battery power of the pump by not requiring the pump to receive, store and later transmit the non-pump data.
- FIG. 1 depicts an embodiment of a pump system according to the disclosure.
- FIG. 2 depicts a block diagram representing an embodiment of a pump system according to the disclosure.
- FIGS. 3A-3C depicts an embodiment of a pump system according to the disclosure.
- FIGS. 4A-4B depict an embodiment of a pump system according to the disclosure.
- FIG. 5 depicts an embodiment of a pump system according to the disclosure.
- FIGS. 6A-6B depict remote control devices for a pump system according to embodiments of the disclosure.
- FIG. 7 depicts a schematic representation of a pump system according to an embodiment of the disclosure.
- FIG. 8 depicts a schematic representation of a pump system according to an embodiment of the disclosure.
- FIGS. 9A-9C depict schematic representations of a pump system according to an embodiment of the disclosure.
- FIG. 10 depicts a schematic representation of a pump system according to an embodiment of the disclosure.
- FIG. 1 depicts an exemplary medical device that can be used with embodiments of the disclosure.
- the medical device is configured as a pump 12 , such as an infusion pump, that can include a pumping or delivery mechanism and reservoir for delivering medicament to a patient and an output/display 44 .
- the type of output/display 44 may vary as may be useful for a particular application.
- the output/display 44 may include an interactive and/or touch sensitive screen 46 having an input device such as, for example, a touch screen comprising a capacitive screen or a resistive screen.
- the pump 12 may additionally include a keyboard, microphone, or other input device known in the art for data entry, which may be separate from the display.
- the pump 12 may also include a capability to operatively couple to one or more blood glucose meters (BGMs) or continuous blood glucose monitors (CGMs) and/or one or more secondary display devices such as a remote display, a remote control device, a laptop computer, personal computer, tablet computer, a mobile communication device such as a smartphone, a wearable electronic watch or electronic health or fitness monitor, or personal digital assistant (PDA), a CGM display etc.
- BGMs blood glucose meters
- CGMs continuous blood glucose monitors
- secondary display devices such as a remote display, a remote control device, a laptop computer, personal computer, tablet computer, a mobile communication device such as a smartphone, a wearable electronic watch or electronic health or fitness monitor, or personal digital assistant (PDA), a CGM display etc.
- BGMs blood glucose meters
- CGMs continuous blood glucose monitors
- secondary display devices such as a remote display, a remote control device, a laptop computer, personal computer, tablet computer, a mobile communication device such as a smartphone,
- the medical device can be a portable pump configured to deliver insulin to a patient. Further details regarding such pump devices can be found in U.S. Pat. No. 8,287,495, which is incorporated herein by reference in its entirety.
- the medical device can be an infusion pump configured to deliver one or more additional or other medicaments to a patient.
- FIG. 2 illustrates a block diagram of some of the features that can be used with embodiments, including features that may be incorporated within the housing 26 of a medical device such as a pump 12 .
- the pump 12 can include a processor 42 that controls the overall functions of the device.
- the infusion pump 12 may also include, e.g., a memory device 30 , a transmitter/receiver 32 , an alarm 34 , a speaker 36 , a clock/timer 38 , an input device 40 , a user interface suitable for accepting input and commands from a user such as a caregiver or patient, a drive mechanism 48 , an estimator device 52 and a microphone (not pictured).
- a user interface as shown in FIG.
- GUI graphical user interface
- the processor 42 may communicate with one or more other processors within the pump 12 and/or one or more processors of other devices, for example, a continuous glucose monitor (CGM), display device, smartphone, etc. through the transmitter/receiver.
- the processor 42 may also include programming that may allow the processor to receive signals and/or other data from one or more input devices, such as sensors that may sense pressure, temperature and/or other parameters.
- FIGS. 3A-3C depict another pump system including a pump 102 that can be used with embodiments.
- Drive unit 118 of pump 102 includes a drive mechanism 122 that mates with a recess in disposable cartridge 116 of pump 102 to attach the cartridge 116 to the drive unit 118 and provide for delivery of medicament such as insulin from the cartridge 116 to a user through a cannula.
- medicament such as insulin from the cartridge 116 to a user through a cannula.
- pump 102 includes a processor that controls operations of the pump and, in some embodiments, may receive commands from a separate device for control of operations of the pump.
- a separate device can include, for example, a dedicated remote control or a smartphone or other consumer electronic device executing an application configured to enable the device to transmit operating commands to the processor of pump 102 .
- processor can also transmit information to one or more separate devices, such as information pertaining to device parameters, alarms, reminders, pump status, etc.
- pump 102 does not include a display but may include one or more indicator lights 174 and/or one or more input buttons 172 . Pump 102 can also incorporate any or all of the features described with respect to pump 12 in FIG. 2 .
- pump system 100 can include a pump 102 and an infusion set 145 .
- FIG. 4A depicts this infusion set 145 as not connected to pump while FIG. 4B depicts infusion set 145 connected to pump 102 via connectors 154 and 152 and tubing 153 .
- Infusion set 145 can include tubing 144 extending between a connector 154 and a site connector 146 .
- Connector 154 can be configured to couple to pump 102 at connector 152 extending from tubing 153 .
- Site connector 146 can be configured to be attached to an infusion site on a user, while pump 102 can be carried in a separate location, such as the user's pocket (as depicted in FIG. 5 ) or another location on the user's body.
- Various lengths of tubing 144 can be used in this embodiment to accommodate the user's preference.
- one or more remote control devices 170 , 171 can be used to communicate with the processor of pump 12 and/or pump 102 to control delivery of medicament and transfer data with pump via a wired or a wireless electromagnetic signal, such as via, e.g., a near field communication (NFC) radio frequency (RF) modality or other RF modalities such as Bluetooth®, Bluetooth® low energy, mobile or Wi-Fi communication protocols, for example, according to embodiments of the present disclosure.
- a remote control can include, for example, a mobile communication device 170 , such as a smart phone (as depicted in FIG. 5 ) executing a software application for control of the pump, a dedicated remote controller 171 (as depicted in FIGS.
- Such communications between (and among) the one or more remote control devices 170 , 171 and pump 102 may be one-way or two-way for, e.g., effective transfer of data among the devices and the pump, control of pump operations, updating software on the devices and/or pump, and allowing pump-related data to be viewed on the devices and/or pump.
- FIG. 7 depicts various components of a pump system 200 according to an embodiment.
- System components can include, for example, a user-wearable infusion pump 202 , a smartphone or other multi-purpose consumer electronic device 204 , remote data storage 206 such as the cloud, one or more optional peripheral devices such as a continuous glucose monitor 208 , and a dedicated remote controller 210 .
- the smartphone 204 and/or the dedicated remote controller 210 can obtain data and information from the cloud, such as a medicament delivery control algorithm and communicate control commands and/or information to the infusion pump 202 and receive data and information from the infusion pump 202 .
- FIG. 1 depicted in FIG.
- the pump 202 can be capable of unidirectional or bidirectional communications via, for example, Bluetooth, with both the remote controller 210 and the smartphone 204 .
- the pump 202 can in various embodiments communicate with a continuous glucose monitor 208 with a corresponding sensor and/or can directly communicate with the CGM sensor.
- Other optional peripheral devices that can communicate with the pump 202 , the smartphone 204 and/or the dedicated remote control device 210 include for example, one or more of a blood glucose meter or other analyte sensing device, an activity or other health monitor, etc.
- the consumer electronic device 204 can alternatively or additional include one or more of a wearable electronic watch, electronic health or fitness monitor, personal digital assistant (PDA), or a tablet, laptop or personal computer, etc.
- PDA personal digital assistant
- a multi-purpose consumer electronic device can be any device sold to consumers and used for a variety of functions and which can be configured or programmed to communicate with and/or control an infusion pump as one of said functions.
- systems as described herein may include more than one multi-purpose consumer electronic device configured for communication with the infusion pump (e.g., a smartphone and an electronic watch).
- systems 200 can include both a dedicated remote controller 210 and a smartphone 204 or other multi-purpose consumer electronic device operating an application capable of communicating with and sending one or more control commands to the pump 202 .
- the smartphone may be provided with a limited set of features and/or commands, such as, for example, display only capability with no control functions, the ability to program and issue bolus commands but no other control commands to the pump, etc., whereas the remote control device may be enabled for full programming and control of all pump functions.
- One concern in systems 200 is that the multiple communication options for the pump can lead to an excessive drain of the pump's rechargeable battery and inefficient and/or redundant communications.
- the present application therefore provides novel communication methods that can aid in reducing the battery drain on a pump while still providing all the advantages of such an integrated communication system.
- FIG. 8 depicts a schematic representation of an infusion pump system 200 including infusion pump 202 , smartphone 204 or other remote consumer electronic device, dedicated remote controller 210 and continuous glucose monitoring system 208 .
- pump 202 can receive glucose information from the CGM system 208 and control commands from both the smartphone 204 and the remote controller 210 .
- Pump 202 can also send communications to these devices. In embodiments, the devices communicate using Bluetooth.
- pump 202 is generally regularly communicating with the CGM system 208 on a periodic basis and is continuously or periodically broadcasting an advertising packet for detection by the phone 204 and the remote controller 210 when not already connected to these devices.
- the pump 202 is depicted as communicating with a monitoring device of the CGM system 208 , the pump can alternatively or additionally communicate directly with the glucose sensor and transmitter of the CGM system.
- the remote 210 is also advertising for detection by the phone 204 .
- the phone 204 is always looking to detect the pump 202 and the remote 210 , which helps conserve the overall battery power of the system because the phone will generally have the largest battery.
- FIGS. 9A-9C schematically depict various communications modalities depending on which elements of system 200 are present.
- the phone 204 has detected the pump 202 but not the remote controller 210 , so the phone 204 communicates directly with the pump.
- the remote controller 210 has detected the pump 202 but the phone 204 is not present such that it has not established a connection with either of the other devices, so the remote controller 210 communicates directly with the pump 202 .
- both the phone 204 and the remote controller are present 210 .
- communications generated by the phone 204 are relayed through the controller 210 to the pump 202 .
- the system is configured in this manner because it can be difficult for the pump 202 to maintain two simultaneous connections with the two control devices for stable and efficient communications and having two simultaneous connections causes a greater burden on the pump battery and therefore drains the battery faster.
- routing the communications through the pump enables availability of all functions of the pump as the phone may not be able to transmit certain communications generated by the controller to the pump.
- preserving battery power of the pump provides the additional benefit of limiting the risk of losing connectivity between the pump 202 and the CGM system 208 that may be used in making therapy determinations due to the pump losing power.
- the phone 204 if the phone 204 subsequently detects the controller 210 , the phone 204 will disconnect from the pump 202 and connect to the controller 210 to route communications through the controller 210 as depicted in FIG. 9C .
- communications could instead be routed through the phone.
- pump 202 is generally continually in communication with CGM system 208 to receive information pertaining to glucose levels and other data.
- the CGM system 208 may provide data every five minutes to the pump 202 . While some of this data such as estimated glucose levels and related data is critical to the functioning of the pump 202 and proper therapy determinations, the data provided by the CGM system includes other data, such as diagnostic data relating to the performance of the CGM sensor and transmitter that is not used by the pump. This data is instead stored in pump memory and later sent from the pump to another device such as a software management system. Requiring the pump to receive, store, and later transmit this additional data that is not utilized by the pump presents another unnecessary drain on the pump battery.
- Such data can include, for example, one or more of sensor and transmitter performance and diagnostic information, various voltage levels, resistance values, battery voltage, temperature data, current data, sensor noise data, radio connectivity logs, wireless quality of service metrics, connectivity history, error messages, alarm/alert history, sensor-transmitter disconnection logging, and/or analysis of any of the above FIG. 10 depicts a system that addresses the foregoing issue by limiting the data in the communications sent from the CGM system 208 to the pump 202 .
- system 200 can be configured such that the CGM system 208 communicates with both the pump 202 and a smartphone 204 or other remote consumer electronic device.
- the CGM system 208 will send only glucose level data and other therapy-relevant data required by the pump to enable proper therapy determinations.
- Other data such as diagnostic data of the CGM system is instead sent to the phone 204 .
- This more limited data sent to the phone 204 helps preserve the battery power of the pump 202 .
- the additional data sent to the phone 204 does not have to be sent as frequently as the therapy related data sent to the pump 202 and could be sent, e.g., every 2-3 hours, twice a day, once a day, etc., which would also help preserve the batteries of the other devices.
- the CGM system 208 can communicate with a dedicated remote controller 210 instead of or in addition to the smartphone 204 .
- infusion pump embodiments herein are specifically described primarily with respect to the delivery of insulin, delivery of other medicaments, singly or in combination with one another or with insulin, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated.
- Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, treatment of various conditions including, e.g., pulmonary hypertension, or any other suitable indication or application.
- Non-medical applications are also contemplated.
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 16/911,631 filed Jun. 25, 2020, which in turn application is a continuation of U.S. application Ser. No. 16/725,278 filed Dec. 23, 2019, now U.S. Pat. No. 10,736,037 issued Aug. 4, 2020, which claims the benefit of U.S. Provisional Application No. 62/784,949 filed Dec. 26, 2018, each of which is hereby incorporated herein in its entirety by reference.
- The present invention is directed to portable infusion pumps and more particularly to systems enabling wireless control of infusion pumps.
- There are a wide variety of medical treatments that include the administration of a therapeutic fluid in precise, known amounts at predetermined intervals. Devices and methods exist that are directed to the delivery of such fluids, which may be liquids or gases, are known in the art.
- One category of such fluid delivery devices includes insulin injecting pumps developed for administering insulin to patients afflicted with type I, or in some cases, type II diabetes. Some insulin injecting pumps are configured as portable or ambulatory infusion devices can provide continuous subcutaneous insulin injection and/or infusion therapy as an alternative to multiple daily injections of insulin via a syringe or an insulin pen. Such pumps are worn by the user and may use replaceable cartridges. In some embodiments, these pumps may also deliver medicaments other than, or in addition to, insulin, such as glucagon, pramlintide, and the like. Examples of such pumps and various features associated therewith include those disclosed in U.S. Patent Publication Nos. 2013/0324928 and 2013/0053816 and U.S. Pat. Nos. 8,287,495; 8,573,027; 8,986,253; and 9,381,297, each of which is incorporated herein by reference in its entirety.
- Ambulatory infusion pumps have generally been controlled by a user interface provided on the pump. With the proliferation of handheld electronic devices, such as mobile phones (e.g., smartphones), there is a desire to be able to remotely utilize such devices, as well as dedicated wireless controllers designed to work with one or more infusion pumps and/or types of infusion pumps, to optimize usage of infusion pumps. These remote controllers would enable a pump to be monitored, programmed and/or operated more privately, more conveniently and more comfortably. Accordingly, one potential use of dedicated remote devices and handheld consumer electronic devices (such as smartphones, tablets and the like) is to utilize such devices as controllers for remotely programming and/or operating infusion pumps.
- However, portable infusion pumps are generally powered by portable batteries and frequent wireless communications with external devices can have a significant effect on infusion pump battery life. In addition to mobile control devices such as smartphones and dedicated remote controllers it may be beneficial to enable infusion pumps to communicate with other devices, such as continuous glucose monitors, glucose meters, and other health monitoring devices, for example. This places further burden on infusion pump battery life. It would therefore be desirable to configure such communications in a manner that reduces the strain on the infusion pump battery and otherwise increase the efficiency of such systems.
- Disclosed herein are methods for establishing communication protocols between wireless devices in infusion pump systems. Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other multi-purpose consumer electronic device and/or a dedicated remote controller for the infusion pump. Communications among these devices can be coordinated to increase efficiency and conserve battery power.
- In embodiments, methods of communication in an infusion pump system in which an infusion pump can communicate with both a smartphone or other multi-purpose consumer electronic device and a dedicated remote controller are coordinated to preserve the pump battery. If only the smartphone or only the remote controller is present in the system at a given time, the device that is present communicates directly with and controls the pump. If the pump, smartphone and remote controller are all present, rather than the smartphone communicating directly with the pump, smartphone communications are instead routed through the remote controller. Similarly, if the smartphone is controlling the pump alone, but then detects that the remote controller has become available for communications, the smartphone will disconnect from the pump and connect to the remote controller to route smartphone communications through the remote controller. This configuration creates more efficient communication and saves battery power because it is difficult for the pump to maintain simultaneous connections to two devices and two connections creates an additional burden on the pump battery. In some configurations, the dedicated remote controller may have full access to program and control the pump while the smartphone has more limited control of pump functionality. In such configurations, routing communications through the remote controller ensures full pump functionality.
- In an embodiment, a method of coordinating wireless communications in an infusion pump system including an infusion pump, a multi-purpose consumer electronic device and a dedicated remote controller designed for use with the infusion pump is provided. The infusion pump can be enabled to receive communications from both the multi-purpose consumer electronic device and the dedicated remote controller and carry out operating commands based on the communications. If it is determined that both the multi-purpose consumer electronic device and the dedicated remote controller are available for communication with the infusion pump, communications can be suspended between the infusion pump and the multi-purpose consumer electronic device. Communications generated by the multi-purpose consumer electronic device can then be routed to the dedicated remote controller and transmitted to the infusion pump with the dedicated remote controller. The infusion pump can execute operating commands based on the communications generated by the multi-purpose consumer electronic device after receiving the communications from the dedicated remote controller.
- In embodiments, communications between an infusion pump and a continuous glucose monitoring (CGM) system in a system that includes a smartphone or other remote control device can be coordinated to preserve pump battery. In an infusion pump system in which the pump utilizes data from a CGM system, the CGM system generally sends data to the pump on a periodic, continual basis, such as, for example, every five minutes. This data includes data sent by the pump in making therapy determinations such as data relating to glucose levels and trends of the patient as well as additional data not used by the pump such as diagnostic data relating to the performance of the CGM components. Communications in the system can be configured to separate the CGM data such that the data needed for therapy determinations is sent to the pump, but the diagnostic data that is not used by the pump is instead transmitted directly from the CGM system to the remote control device. Having this data go directly from the CGM to the remote control device lessens the effect of receiving, storing and transmitting the CGM data on the pump battery.
- In an embodiment, a method of coordinating wireless communications in an infusion pump system including an infusion pump, a remote control device for remotely controlling the infusion pump, and a continuous glucose monitoring system is provided. Data can be collected with the continuous glucose monitoring system and wireless communication established between the continuous glucose monitoring system and both the infusion pump and the remote control device. The data collected with the continuous glucose monitoring system can be separated into pump data that will be utilized to determine therapy parameters for the infusion pump and non-pump data relating to the continuous glucose monitoring system that are not used to determine therapy parameters for the infusion pump. The pump data can be transmitted to the infusion pump and the non-pump data to the remote control device to conserve battery power of the pump by not requiring the pump to receive, store and later transmit the non-pump data.
- The above summary is not intended to describe each illustrated embodiment or every implementation of the subject matter hereof. The figures and the detailed description that follow more particularly exemplify various embodiments.
- Subject matter hereof may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying figures, in which:
-
FIG. 1 depicts an embodiment of a pump system according to the disclosure. -
FIG. 2 depicts a block diagram representing an embodiment of a pump system according to the disclosure. -
FIGS. 3A-3C depicts an embodiment of a pump system according to the disclosure. -
FIGS. 4A-4B depict an embodiment of a pump system according to the disclosure. -
FIG. 5 depicts an embodiment of a pump system according to the disclosure. -
FIGS. 6A-6B depict remote control devices for a pump system according to embodiments of the disclosure. -
FIG. 7 depicts a schematic representation of a pump system according to an embodiment of the disclosure. -
FIG. 8 depicts a schematic representation of a pump system according to an embodiment of the disclosure. -
FIGS. 9A-9C depict schematic representations of a pump system according to an embodiment of the disclosure. -
FIG. 10 depicts a schematic representation of a pump system according to an embodiment of the disclosure. - While various embodiments are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the claimed inventions to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the subject matter as defined by the claims.
- The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
-
FIG. 1 depicts an exemplary medical device that can be used with embodiments of the disclosure. In this embodiment, the medical device is configured as apump 12, such as an infusion pump, that can include a pumping or delivery mechanism and reservoir for delivering medicament to a patient and an output/display 44. The type of output/display 44 may vary as may be useful for a particular application. The output/display 44 may include an interactive and/or touchsensitive screen 46 having an input device such as, for example, a touch screen comprising a capacitive screen or a resistive screen. Thepump 12 may additionally include a keyboard, microphone, or other input device known in the art for data entry, which may be separate from the display. Thepump 12 may also include a capability to operatively couple to one or more blood glucose meters (BGMs) or continuous blood glucose monitors (CGMs) and/or one or more secondary display devices such as a remote display, a remote control device, a laptop computer, personal computer, tablet computer, a mobile communication device such as a smartphone, a wearable electronic watch or electronic health or fitness monitor, or personal digital assistant (PDA), a CGM display etc. - In one embodiment, the medical device can be a portable pump configured to deliver insulin to a patient. Further details regarding such pump devices can be found in U.S. Pat. No. 8,287,495, which is incorporated herein by reference in its entirety. In other embodiments, the medical device can be an infusion pump configured to deliver one or more additional or other medicaments to a patient.
-
FIG. 2 illustrates a block diagram of some of the features that can be used with embodiments, including features that may be incorporated within thehousing 26 of a medical device such as apump 12. Thepump 12 can include aprocessor 42 that controls the overall functions of the device. Theinfusion pump 12 may also include, e.g., amemory device 30, a transmitter/receiver 32, analarm 34, aspeaker 36, a clock/timer 38, aninput device 40, a user interface suitable for accepting input and commands from a user such as a caregiver or patient, adrive mechanism 48, anestimator device 52 and a microphone (not pictured). One embodiment of a user interface as shown inFIG. 2 is a graphical user interface (GUI) 60 having a touchsensitive screen 46 with input capability. In some embodiments, theprocessor 42 may communicate with one or more other processors within thepump 12 and/or one or more processors of other devices, for example, a continuous glucose monitor (CGM), display device, smartphone, etc. through the transmitter/receiver. Theprocessor 42 may also include programming that may allow the processor to receive signals and/or other data from one or more input devices, such as sensors that may sense pressure, temperature and/or other parameters. -
FIGS. 3A-3C depict another pump system including apump 102 that can be used with embodiments.Drive unit 118 ofpump 102 includes adrive mechanism 122 that mates with a recess indisposable cartridge 116 ofpump 102 to attach thecartridge 116 to thedrive unit 118 and provide for delivery of medicament such as insulin from thecartridge 116 to a user through a cannula. Further details regarding such pumps can be found in U.S. patent application Ser. No. 14/707,851 filed May 8, 2015 and U.S. Patent Publication Nos. 2016/0339172 and 2017/0049957, each of which is hereby incorporated herein by reference in its entirety. - In one embodiment, pump 102 includes a processor that controls operations of the pump and, in some embodiments, may receive commands from a separate device for control of operations of the pump. Such a separate device can include, for example, a dedicated remote control or a smartphone or other consumer electronic device executing an application configured to enable the device to transmit operating commands to the processor of
pump 102. In some embodiments, processor can also transmit information to one or more separate devices, such as information pertaining to device parameters, alarms, reminders, pump status, etc. In oneembodiment pump 102 does not include a display but may include one ormore indicator lights 174 and/or one ormore input buttons 172. Pump 102 can also incorporate any or all of the features described with respect to pump 12 inFIG. 2 . - As depicted in the embodiment of
FIGS. 4A-4B ,pump system 100 can include apump 102 and aninfusion set 145.FIG. 4A depicts this infusion set 145 as not connected to pump whileFIG. 4B depicts infusion set 145 connected to pump 102 viaconnectors tubing 153. Infusion set 145 can includetubing 144 extending between aconnector 154 and asite connector 146.Connector 154 can be configured to couple to pump 102 atconnector 152 extending fromtubing 153.Site connector 146 can be configured to be attached to an infusion site on a user, whilepump 102 can be carried in a separate location, such as the user's pocket (as depicted inFIG. 5 ) or another location on the user's body. Various lengths oftubing 144 can be used in this embodiment to accommodate the user's preference. - Referring to
FIGS. 5-6B , one or moreremote control devices pump 12 and/or pump 102 to control delivery of medicament and transfer data with pump via a wired or a wireless electromagnetic signal, such as via, e.g., a near field communication (NFC) radio frequency (RF) modality or other RF modalities such as Bluetooth®, Bluetooth® low energy, mobile or Wi-Fi communication protocols, for example, according to embodiments of the present disclosure. Such a remote control can include, for example, amobile communication device 170, such as a smart phone (as depicted inFIG. 5 ) executing a software application for control of the pump, a dedicated remote controller 171 (as depicted inFIGS. 6A-6B ), a wearable electronic watch or electronic health or fitness monitor or personal digital assistant (PDA), etc., or a tablet, laptop or personal computer. Such communications between (and among) the one or moreremote control devices -
FIG. 7 depicts various components of apump system 200 according to an embodiment. System components can include, for example, a user-wearable infusion pump 202, a smartphone or other multi-purpose consumerelectronic device 204,remote data storage 206 such as the cloud, one or more optional peripheral devices such as a continuous glucose monitor 208, and a dedicatedremote controller 210. In the depicted embodiment, thesmartphone 204 and/or the dedicatedremote controller 210 can obtain data and information from the cloud, such as a medicament delivery control algorithm and communicate control commands and/or information to theinfusion pump 202 and receive data and information from theinfusion pump 202. As depicted inFIG. 7 , thepump 202 can be capable of unidirectional or bidirectional communications via, for example, Bluetooth, with both theremote controller 210 and thesmartphone 204. Thepump 202 can in various embodiments communicate with a continuous glucose monitor 208 with a corresponding sensor and/or can directly communicate with the CGM sensor. Other optional peripheral devices that can communicate with thepump 202, thesmartphone 204 and/or the dedicatedremote control device 210 include for example, one or more of a blood glucose meter or other analyte sensing device, an activity or other health monitor, etc. - Although depicted with the multi-purpose consumer
electronic device 204 being a smartphone, in various embodiments the consumer electronic device can alternatively or additional include one or more of a wearable electronic watch, electronic health or fitness monitor, personal digital assistant (PDA), or a tablet, laptop or personal computer, etc. A multi-purpose consumer electronic device can be any device sold to consumers and used for a variety of functions and which can be configured or programmed to communicate with and/or control an infusion pump as one of said functions. In some embodiments, systems as described herein may include more than one multi-purpose consumer electronic device configured for communication with the infusion pump (e.g., a smartphone and an electronic watch). - As noted above, systems 200 (such as the system depicted by way of example in
FIG. 7 ) can include both a dedicatedremote controller 210 and asmartphone 204 or other multi-purpose consumer electronic device operating an application capable of communicating with and sending one or more control commands to thepump 202. For example, in some embodiments the smartphone may be provided with a limited set of features and/or commands, such as, for example, display only capability with no control functions, the ability to program and issue bolus commands but no other control commands to the pump, etc., whereas the remote control device may be enabled for full programming and control of all pump functions. - One concern in systems 200 (such as the system depicted by way of example in
FIG. 7 ) is that the multiple communication options for the pump can lead to an excessive drain of the pump's rechargeable battery and inefficient and/or redundant communications. The present application therefore provides novel communication methods that can aid in reducing the battery drain on a pump while still providing all the advantages of such an integrated communication system. -
FIG. 8 depicts a schematic representation of aninfusion pump system 200 includinginfusion pump 202,smartphone 204 or other remote consumer electronic device, dedicatedremote controller 210 and continuousglucose monitoring system 208. As noted above, pump 202 can receive glucose information from theCGM system 208 and control commands from both thesmartphone 204 and theremote controller 210. Pump 202 can also send communications to these devices. In embodiments, the devices communicate using Bluetooth. In the depicted embodiment, pump 202 is generally regularly communicating with theCGM system 208 on a periodic basis and is continuously or periodically broadcasting an advertising packet for detection by thephone 204 and theremote controller 210 when not already connected to these devices. Note that although thepump 202 is depicted as communicating with a monitoring device of theCGM system 208, the pump can alternatively or additionally communicate directly with the glucose sensor and transmitter of the CGM system. The remote 210 is also advertising for detection by thephone 204. Thephone 204 is always looking to detect thepump 202 and the remote 210, which helps conserve the overall battery power of the system because the phone will generally have the largest battery. -
FIGS. 9A-9C schematically depict various communications modalities depending on which elements ofsystem 200 are present. InFIG. 9A , thephone 204 has detected thepump 202 but not theremote controller 210, so thephone 204 communicates directly with the pump. InFIG. 9B , theremote controller 210 has detected thepump 202 but thephone 204 is not present such that it has not established a connection with either of the other devices, so theremote controller 210 communicates directly with thepump 202. - In
FIG. 9C , both thephone 204 and the remote controller are present 210. In this situation, rather than thepump 202 communicating with both thecontroller 210 and thephone 204, communications generated by thephone 204 are relayed through thecontroller 210 to thepump 202. The system is configured in this manner because it can be difficult for thepump 202 to maintain two simultaneous connections with the two control devices for stable and efficient communications and having two simultaneous connections causes a greater burden on the pump battery and therefore drains the battery faster. In an embodiment such as described above in which the phone may be limited to certain control functions, routing the communications through the pump enables availability of all functions of the pump as the phone may not be able to transmit certain communications generated by the controller to the pump. In addition to prolonging the use of the pump between charges, preserving battery power of the pump provides the additional benefit of limiting the risk of losing connectivity between thepump 202 and theCGM system 208 that may be used in making therapy determinations due to the pump losing power. - Referring again to
FIG. 9A in which theremote controller 210 is not present, if thephone 204 subsequently detects thecontroller 210, thephone 204 will disconnect from thepump 202 and connect to thecontroller 210 to route communications through thecontroller 210 as depicted inFIG. 9C . In alternative embodiments, particularly in embodiments where the phone has full control of the pump, communications could instead be routed through the phone. - As shown and described above with respect to
system 200, pump 202 is generally continually in communication withCGM system 208 to receive information pertaining to glucose levels and other data. For example, theCGM system 208 may provide data every five minutes to thepump 202. While some of this data such as estimated glucose levels and related data is critical to the functioning of thepump 202 and proper therapy determinations, the data provided by the CGM system includes other data, such as diagnostic data relating to the performance of the CGM sensor and transmitter that is not used by the pump. This data is instead stored in pump memory and later sent from the pump to another device such as a software management system. Requiring the pump to receive, store, and later transmit this additional data that is not utilized by the pump presents another unnecessary drain on the pump battery. Such data can include, for example, one or more of sensor and transmitter performance and diagnostic information, various voltage levels, resistance values, battery voltage, temperature data, current data, sensor noise data, radio connectivity logs, wireless quality of service metrics, connectivity history, error messages, alarm/alert history, sensor-transmitter disconnection logging, and/or analysis of any of the aboveFIG. 10 depicts a system that addresses the foregoing issue by limiting the data in the communications sent from theCGM system 208 to thepump 202. As can be seen inFIG. 10 ,system 200 can be configured such that theCGM system 208 communicates with both thepump 202 and asmartphone 204 or other remote consumer electronic device. In the depicted configuration, theCGM system 208 will send only glucose level data and other therapy-relevant data required by the pump to enable proper therapy determinations. Other data, such as diagnostic data of the CGM system is instead sent to thephone 204. This more limited data sent to thephone 204 helps preserve the battery power of thepump 202. In addition, the additional data sent to thephone 204 does not have to be sent as frequently as the therapy related data sent to thepump 202 and could be sent, e.g., every 2-3 hours, twice a day, once a day, etc., which would also help preserve the batteries of the other devices. In other embodiments, theCGM system 208 can communicate with a dedicatedremote controller 210 instead of or in addition to thesmartphone 204. - Although the embodiments herein have been specifically described with respect to an ambulatory infusion pump, the inventions disclosed herein could be employed with any other type of programmable medical device capable of receiving and executing remote commands. Such devices include, for example, implantable pumps, defibrillators, spinal cord stimulation systems, etc. Embodiments could further include non-medical applications.
- Although the infusion pump embodiments herein are specifically described primarily with respect to the delivery of insulin, delivery of other medicaments, singly or in combination with one another or with insulin, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, treatment of various conditions including, e.g., pulmonary hypertension, or any other suitable indication or application. Non-medical applications are also contemplated.
- Also incorporated herein by reference in their entirety are commonly owned U.S. Pat. Nos. 6,999,854; 8,133,197; 8,287,495; 8,408,421 8,448,824; 8,573,027; 8,650,937; 8,986,523; 9,173,998; 9,180,242; 9,180,243; 9,238,100; 9,242,043; 9,335,910; 9,381,271; 9,421,329; 9,486,171; 9,486,571; 9,492,608; 9,503,526; 9,555,186; 9,565,718; 9,603,995; 9,669,160; 9,715,327; 9,737,656; 9,750,871; 9,867,937; 9,867,953; 9,940,441; 9,993,595; 10,016,561; 10,201,656; 10,279,105; 10,279,106; 10,279,107; 10,357,603; 10,357,606; 10,492,141. commonly owned U.S. Patent Publication Nos. 2009/0287180; 2012/0123230; 2013/0053816; 2014/0276423; 2014/0276569; 2014/0276570; 2017/0182248; 2017/0250971; 2018/0021514; 2018/0071454; 2019/0240398; 2019/0307952; and 2019/0365997 and commonly owned U.S. patent application Ser. Nos. 16/507,146 and 16/598,343.
- Further incorporated by reference herein in their entirety are U.S. Pat. Nos. 8,601,465; 8,502,662; 8,452,953; 8,451,230; 8,449,523; 8,444,595; 8,343,092; 8,285,328; 8,126,728; 8,117,481; 8,095,123; 7,999,674; 7,819,843; 7,782,192; 7,109,878; 6,997,920; 6,979,326; 6,936,029; 6,872,200; 6,813,519; 6,641,533; 6,554,798; 6,551,276; 6,295,506; and 5,665,065.
- Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the claimed inventions. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, configurations and locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the claimed inventions.
- Persons of ordinary skill in the relevant arts will recognize that the subject matter hereof may comprise fewer features than illustrated in any individual embodiment described above. The embodiments described herein are not meant to be an exhaustive presentation of the ways in which the various features of the subject matter hereof may be combined. Accordingly, the embodiments are not mutually exclusive combinations of features; rather, the various embodiments can comprise a combination of different individual features selected from different individual embodiments, as understood by persons of ordinary skill in the art. Moreover, elements described with respect to one embodiment can be implemented in other embodiments even when not described in such embodiments unless otherwise noted.
- Although a dependent claim may refer in the claims to a specific combination with one or more other claims, other embodiments can also include a combination of the dependent claim with the subject matter of each other dependent claim or a combination of one or more features with other dependent or independent claims. Such combinations are proposed herein unless it is stated that a specific combination is not intended.
- For purposes of interpreting the claims, it is expressly intended that the provisions of 35 U.S.C. § 112(f) are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/395,289 US20210368442A1 (en) | 2018-12-26 | 2021-08-05 | Methods of wireless communication in an infusion pump system |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862784949P | 2018-12-26 | 2018-12-26 | |
US16/725,278 US10736037B2 (en) | 2018-12-26 | 2019-12-23 | Methods of wireless communication in an infusion pump system |
US16/911,631 US11109316B2 (en) | 2018-12-26 | 2020-06-25 | Methods of wireless communication in an infusion pump system |
US17/395,289 US20210368442A1 (en) | 2018-12-26 | 2021-08-05 | Methods of wireless communication in an infusion pump system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/911,631 Continuation US11109316B2 (en) | 2018-12-26 | 2020-06-25 | Methods of wireless communication in an infusion pump system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210368442A1 true US20210368442A1 (en) | 2021-11-25 |
Family
ID=71123532
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/725,278 Active US10736037B2 (en) | 2018-12-26 | 2019-12-23 | Methods of wireless communication in an infusion pump system |
US16/911,631 Active US11109316B2 (en) | 2018-12-26 | 2020-06-25 | Methods of wireless communication in an infusion pump system |
US17/395,289 Pending US20210368442A1 (en) | 2018-12-26 | 2021-08-05 | Methods of wireless communication in an infusion pump system |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/725,278 Active US10736037B2 (en) | 2018-12-26 | 2019-12-23 | Methods of wireless communication in an infusion pump system |
US16/911,631 Active US11109316B2 (en) | 2018-12-26 | 2020-06-25 | Methods of wireless communication in an infusion pump system |
Country Status (1)
Country | Link |
---|---|
US (3) | US10736037B2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10492141B2 (en) | 2015-11-17 | 2019-11-26 | Tandem Diabetes Care, Inc. | Methods for reduction of battery usage in ambulatory infusion pumps |
CN108348679A (en) | 2015-11-20 | 2018-07-31 | 先进微流控技术股份公司 | Micropump |
US11529458B2 (en) | 2017-12-08 | 2022-12-20 | Amf Medical Sa | Drug delivery device |
US10736037B2 (en) | 2018-12-26 | 2020-08-04 | Tandem Diabetes Care, Inc. | Methods of wireless communication in an infusion pump system |
WO2020171838A1 (en) | 2019-02-19 | 2020-08-27 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
WO2020198422A1 (en) | 2019-03-26 | 2020-10-01 | Tandem Diabetes Care, Inc. | Method of pairing an infusion pump with a remote control device |
US11529461B1 (en) | 2021-06-01 | 2022-12-20 | Amf Medical Sa | Initialization for systems and methods for delivering microdoses of medication |
US11679199B2 (en) | 2021-06-01 | 2023-06-20 | Amf Medical Sa | Systems and methods for delivering microdoses of medication |
US11857757B2 (en) | 2021-06-01 | 2024-01-02 | Tandem Diabetes Care Switzerland Sàrl | Systems and methods for delivering microdoses of medication |
Family Cites Families (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6241704B1 (en) | 1901-11-22 | 2001-06-05 | Sims Deltec, Inc. | Drug pump systems and methods |
US20010011224A1 (en) | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
DE19840965A1 (en) | 1998-09-08 | 2000-03-09 | Disetronic Licensing Ag | Device for self-administration of a product fluid |
US7991625B2 (en) | 1999-06-23 | 2011-08-02 | Koninklijke Philips Electronics N.V. | System for providing expert care to a basic care medical facility from a remote location |
US7181505B2 (en) | 1999-07-07 | 2007-02-20 | Medtronic, Inc. | System and method for remote programming of an implantable medical device |
AU7780700A (en) | 1999-10-01 | 2001-05-10 | Glaxo Group Limited | Remote patient assessment system |
US6602191B2 (en) | 1999-12-17 | 2003-08-05 | Q-Tec Systems Llp | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
DK1347705T3 (en) | 2000-12-21 | 2006-03-27 | Insulet Corp | Medical device for remote control |
AU2002309528A1 (en) | 2001-04-02 | 2002-10-15 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
EP1320322A1 (en) | 2001-08-20 | 2003-06-25 | Inverness Medical Limited | Wireless diabetes management devices and methods for using the same |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
EP1843812A4 (en) | 2005-02-01 | 2008-12-03 | Intelliject Llc | Devices, systems, and methods for medicament delivery |
AU2006226988B2 (en) | 2005-03-21 | 2011-12-01 | Abbott Diabetes Care, Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US8095123B2 (en) | 2005-06-13 | 2012-01-10 | Roche Diagnostics International Ag | Wireless communication system |
US20070093786A1 (en) | 2005-08-16 | 2007-04-26 | Medtronic Minimed, Inc. | Watch controller for a medical device |
US20070060870A1 (en) | 2005-08-16 | 2007-03-15 | Tolle Mike Charles V | Controller device for an infusion pump |
US20070060869A1 (en) | 2005-08-16 | 2007-03-15 | Tolle Mike C V | Controller device for an infusion pump |
US20090227855A1 (en) | 2005-08-16 | 2009-09-10 | Medtronic Minimed, Inc. | Controller device for an infusion pump |
EP1758039A1 (en) | 2005-08-27 | 2007-02-28 | Roche Diagnostics GmbH | Communication adaptor for portable medical or therapeutical devices |
JP4449890B2 (en) * | 2005-11-21 | 2010-04-14 | ソニー株式会社 | Transfer substrate, transfer method, and display device manufacturing method |
FI120716B (en) | 2005-12-20 | 2010-02-15 | Smart Valley Software Oy | A method for measuring and analyzing the movements of a human or animal using audio signals |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
EP1997233B1 (en) | 2006-03-13 | 2014-03-05 | Novo Nordisk A/S | Secure pairing of electronic devices using dual means of communication |
US20070255126A1 (en) | 2006-04-28 | 2007-11-01 | Moberg Sheldon B | Data communication in networked fluid infusion systems |
US20070253021A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic Minimed, Inc. | Identification of devices in a medical device network and wireless data communication techniques utilizing device identifiers |
US20070255125A1 (en) | 2006-04-28 | 2007-11-01 | Moberg Sheldon B | Monitor devices for networked fluid infusion systems |
US8149131B2 (en) | 2006-08-03 | 2012-04-03 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
US8025634B1 (en) | 2006-09-18 | 2011-09-27 | Baxter International Inc. | Method and system for controlled infusion of therapeutic substances |
US20080097912A1 (en) | 2006-10-24 | 2008-04-24 | Kent Dicks | Systems and methods for wireless processing and transmittal of medical data through an intermediary device |
US8126730B2 (en) | 2006-10-24 | 2012-02-28 | Medapps, Inc. | Systems and methods for storage and forwarding of medical data |
US20080097917A1 (en) | 2006-10-24 | 2008-04-24 | Kent Dicks | Systems and methods for wireless processing and medical device monitoring via remote command execution |
US8126728B2 (en) | 2006-10-24 | 2012-02-28 | Medapps, Inc. | Systems and methods for processing and transmittal of medical data through an intermediary device |
US20080215360A1 (en) | 2006-10-24 | 2008-09-04 | Kent Dicks | Systems and methods for medical data interchange interface |
US8121857B2 (en) * | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
US8221345B2 (en) | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
US20080300572A1 (en) | 2007-06-01 | 2008-12-04 | Medtronic Minimed, Inc. | Wireless monitor for a personal medical device system |
CA2688184A1 (en) | 2007-06-08 | 2008-12-18 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
EP2001188A1 (en) | 2007-06-08 | 2008-12-10 | F.Hoffmann-La Roche Ag | Method for authenticating a medical device and a remote device |
WO2009005960A2 (en) | 2007-06-29 | 2009-01-08 | Roche Diagnostics Gmbh | Method and apparatus for determining and delivering a drug bolus |
CN101821722A (en) * | 2007-06-29 | 2010-09-01 | 霍夫曼-拉罗奇有限公司 | Device and methods for optimizing communications between medical device and a remote electronic device |
EP2031527A1 (en) | 2007-07-27 | 2009-03-04 | Sensile Pat AG | Portable medical device |
US7717903B2 (en) | 2007-09-06 | 2010-05-18 | M2 Group Holdings, Inc. | Operating an infusion pump system |
US20090177142A1 (en) | 2008-01-09 | 2009-07-09 | Smiths Medical Md, Inc | Insulin pump with add-on modules |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
US7938797B2 (en) | 2008-05-05 | 2011-05-10 | Asante Solutions, Inc. | Infusion pump system |
US8117481B2 (en) | 2008-06-06 | 2012-02-14 | Roche Diagnostics International Ag | Apparatus and method for processing wirelessly communicated information within an electronic device |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
US8287487B2 (en) | 2008-10-15 | 2012-10-16 | Asante Solutions, Inc. | Infusion pump system and methods |
US8974439B2 (en) | 2009-01-02 | 2015-03-10 | Asante Solutions, Inc. | Infusion pump system and methods |
CA2753214C (en) | 2009-02-27 | 2017-07-25 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
US8372351B2 (en) | 2009-05-29 | 2013-02-12 | Abbott Diabetes Care Inc. | Glucose monitoring system with wireless communications |
GR20090100384A (en) | 2009-07-08 | 2011-02-18 | Αχιλλεας Τσουκαλης | Insulin pump |
WO2011014704A2 (en) | 2009-07-30 | 2011-02-03 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US20110034792A1 (en) | 2009-08-05 | 2011-02-10 | Williams Ronald L | Noninvasive Body Chemistry Monitor and Method |
US10195343B2 (en) * | 2010-02-05 | 2019-02-05 | Deka Products Limited Partnership | Devices, methods and systems for wireless control of medical devices |
US9662438B2 (en) * | 2010-02-05 | 2017-05-30 | Deka Products Limited Partnership | Devices, methods and systems for wireless control of medical devices |
US9750896B2 (en) * | 2010-02-05 | 2017-09-05 | Deka Products Limited Partnership | Infusion pump apparatus, method and system |
US20120123230A1 (en) | 2010-10-13 | 2012-05-17 | Tandem Diebetes Care, Inc. | Analyte monitoring systems and methods of use |
US8454554B2 (en) | 2010-10-15 | 2013-06-04 | Roche Diagnostics Operations, Inc. | Use of a handheld medical device as a communications mediator between a personal computer-based configurator and another networked medical device |
US8478237B1 (en) * | 2010-11-23 | 2013-07-02 | Robert Stenta | Dual-mode vehicle mobile phone disabler |
US8634348B2 (en) * | 2010-12-29 | 2014-01-21 | Motorola Mobility Llc | Method and system for facilitating wireless communication via alternate wireless pathway |
US8454581B2 (en) | 2011-03-16 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump systems and methods |
US9323893B2 (en) | 2011-06-23 | 2016-04-26 | Orca Health, Inc. | Using mobile consumer devices to communicate with consumer medical devices |
US8495226B2 (en) * | 2011-07-14 | 2013-07-23 | Verizon Patent And Licensing Inc. | Data path selection method for communication session |
US9642568B2 (en) * | 2011-09-06 | 2017-05-09 | Medtronic Minimed, Inc. | Orthogonally redundant sensor systems and methods |
US9335910B2 (en) | 2012-04-23 | 2016-05-10 | Tandem Diabetes Care, Inc. | System and method for reduction of inadvertent activation of medical device during manipulation |
US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US9381297B2 (en) | 2012-06-07 | 2016-07-05 | Tandem Diabetes Care, Inc. | Sealed infusion device with electrical connector port |
US9715327B2 (en) | 2012-06-07 | 2017-07-25 | Tandem Diabetes Care, Inc. | Preventing inadvertent changes in ambulatory medical devices |
US9966997B2 (en) * | 2012-09-17 | 2018-05-08 | Stryker Corporation | Communication systems for patient support apparatuses |
US9901677B2 (en) | 2012-10-16 | 2018-02-27 | Bigfoot Biomedical, Inc. | Infusion pump system and methods |
US10063499B2 (en) * | 2013-03-07 | 2018-08-28 | Samsung Electronics Co., Ltd. | Non-cloud based communication platform for an environment control system |
US9242043B2 (en) | 2013-03-15 | 2016-01-26 | Tandem Diabetes Care, Inc. | Field update of an ambulatory infusion pump system |
US9565718B2 (en) | 2013-09-10 | 2017-02-07 | Tandem Diabetes Care, Inc. | System and method for detecting and transmitting medical device alarm with a smartphone application |
EP4250313A3 (en) | 2013-12-26 | 2023-11-22 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
EP3087548A4 (en) | 2013-12-26 | 2017-09-13 | Tandem Diabetes Care, Inc. | Safety processor for wireless control of a drug delivery device |
US10279106B1 (en) | 2014-05-08 | 2019-05-07 | Tandem Diabetes Care, Inc. | Insulin patch pump |
US9408129B2 (en) * | 2014-06-17 | 2016-08-02 | Gogo Llc | Multiple modem communication system and method for a mobile platform |
US10091197B2 (en) * | 2015-01-16 | 2018-10-02 | Digimarc Corporation | Configuring, controlling and monitoring computers using mobile devices |
CN107106042A (en) * | 2015-01-21 | 2017-08-29 | 德克斯康公司 | Continuous Glucose monitor and the communication of multiple display devices |
EP4339825A1 (en) * | 2015-05-12 | 2024-03-20 | Dexcom, Inc. | Distributed system architecture for continuous glucose monitoring |
US9993595B2 (en) | 2015-05-18 | 2018-06-12 | Tandem Diabetes Care, Inc. | Patch pump cartridge attachment |
CN108348677B (en) | 2015-08-20 | 2020-10-27 | 坦德姆糖尿病护理股份有限公司 | Drive mechanism for a perfusion pump |
US10492141B2 (en) | 2015-11-17 | 2019-11-26 | Tandem Diabetes Care, Inc. | Methods for reduction of battery usage in ambulatory infusion pumps |
US20190215729A1 (en) * | 2018-03-15 | 2019-07-11 | Intel Corporation | Session description protocol mechanisms for signaling radio access network capabilities in multimedia telephony sessions |
WO2019199952A1 (en) | 2018-04-10 | 2019-10-17 | Tandem Diabetes Care, Inc. | System and method for inductively charging a medical device |
US10904128B2 (en) * | 2018-09-13 | 2021-01-26 | International Business Machines Corporation | Testing functionality of an Internet of Things environment |
US11071821B2 (en) * | 2018-09-28 | 2021-07-27 | Medtronic Minimed, Inc. | Insulin infusion device with efficient confirmation routine for blood glucose measurements |
US10736037B2 (en) | 2018-12-26 | 2020-08-04 | Tandem Diabetes Care, Inc. | Methods of wireless communication in an infusion pump system |
US20200206420A1 (en) | 2018-12-26 | 2020-07-02 | Tandem Diabetes Care, Inc. | Methods of wireless communication in an infusion pump system |
-
2019
- 2019-12-23 US US16/725,278 patent/US10736037B2/en active Active
-
2020
- 2020-06-25 US US16/911,631 patent/US11109316B2/en active Active
-
2021
- 2021-08-05 US US17/395,289 patent/US20210368442A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11109316B2 (en) | 2021-08-31 |
US20200329433A1 (en) | 2020-10-15 |
US20200213946A1 (en) | 2020-07-02 |
US10736037B2 (en) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10736037B2 (en) | Methods of wireless communication in an infusion pump system | |
US11838867B2 (en) | Methods for reduction of battery usage in ambulatory infusion pumps | |
US11324898B2 (en) | System and method for infusion set dislodgement detection | |
US20220134001A1 (en) | System and method for switching between medicament delivery control algorithms | |
US10357603B2 (en) | Electromagnetic signal-based infusion pump control | |
CA2669294C (en) | Analyte sensing apparatus for hospital use | |
JP5451678B2 (en) | Detection system with auxiliary display | |
US11464908B2 (en) | Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps | |
US20200206420A1 (en) | Methods of wireless communication in an infusion pump system | |
EP2355865A2 (en) | Remote control for fluid dispensing device with a rechargeable power source | |
US20230166033A1 (en) | Bolus permissions and prioritization scheme for infusion pump system | |
US20230113545A1 (en) | Alerts in ambulatory infusion pump systems | |
WO2024010974A1 (en) | Insulin pump with integrated continuous glucose monitor | |
WO2023014660A1 (en) | Systems and methods for processing continuous glucose monitor values in automated insulin delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: TANDEM DIABETES CARE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KRUSE, GEOFFREY A.;MICHAUD, MICHAEL;SIGNING DATES FROM 20200122 TO 20200128;REEL/FRAME:058044/0228 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:TANDEM DIABETES CARE, INC.;REEL/FRAME:060179/0100 Effective date: 20220518 |
|
AS | Assignment |
Owner name: TANDEM DIABETES CARE, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:066880/0918 Effective date: 20240319 |